Invention Grant
- Patent Title: Amyloid-beta-binding peptides and the use thereof for the treatment and diagnosis of alzheimer's disease
-
Application No.: US15022749Application Date: 2014-09-23
-
Publication No.: US10995118B2Publication Date: 2021-05-04
- Inventor: Dieter Willbold
- Applicant: FORSCHUNGSZENTRUM JUELICH GMBH
- Applicant Address: DE Juelich
- Assignee: FORSCHUNGSZENTRUM JUELICH GMBH
- Current Assignee: FORSCHUNGSZENTRUM JUELICH GMBH
- Current Assignee Address: DE Juelich
- Agency: Norris McLaughlin, P.A.
- Priority: DEDE102013016002.2 20130926,DEDE102014003262.0 20140312
- International Application: PCT/DE2014/000477 WO 20140923
- International Announcement: WO2015/043567 WO 20150402
- Main IPC: C07K7/08
- IPC: C07K7/08 ; G01N33/68 ; A61K38/10 ; A61K38/16 ; A61K38/12 ; A61K38/00
Abstract:
Amyloid beta-binding peptides and the use thereof for the treatment and the diagnosis of Alzheimer's disease.
Public/Granted literature
- US20200002379A9 AMYLOID-BETA-BINDING PEPTIDES AND THE USE THEREOF FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE Public/Granted day:2020-01-02
Information query
